m-a-istock-537908812
designer491 / iStockphoto.com
2 January 2018Americas

Mallinckrodt to make $1.2bn acquisition

Mallinckrodt has revealed plans to acquire biopharmaceutical company Sucampo Pharmaceuticals for $1.2 billion.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Americas
7 August 2017   Mallinckrodt has acquired InfaCare Pharmaceutical Corporation, a company specialising in the development and commercialisation of pharmaceuticals for neonatal and paediatric patients.
Americas
21 May 2018   The US Court of Appeals for the Federal Circuit has affirmed a patent victory for industrial gases company Praxair against pharmaceutical business Mallinckrodt.

More on this story

Americas
7 August 2017   Mallinckrodt has acquired InfaCare Pharmaceutical Corporation, a company specialising in the development and commercialisation of pharmaceuticals for neonatal and paediatric patients.
Americas
21 May 2018   The US Court of Appeals for the Federal Circuit has affirmed a patent victory for industrial gases company Praxair against pharmaceutical business Mallinckrodt.

More on this story

Americas
7 August 2017   Mallinckrodt has acquired InfaCare Pharmaceutical Corporation, a company specialising in the development and commercialisation of pharmaceuticals for neonatal and paediatric patients.
Americas
21 May 2018   The US Court of Appeals for the Federal Circuit has affirmed a patent victory for industrial gases company Praxair against pharmaceutical business Mallinckrodt.